BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24599890)

  • 1. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the adverse effects associated with ecstasy use.
    Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
    Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Typology of new psychoactive substance use among the general Australian population.
    Sutherland R; Peacock A; Roxburgh A; Barratt MJ; Burns L; Bruno R
    Drug Alcohol Depend; 2018 Jul; 188():126-134. PubMed ID: 29775956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
    Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
    Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the use of ecstasy and hallucinogens increasing? Results from a community study.
    Schuster P; Lieb R; Lamertz C; Wittchen HU
    Eur Addict Res; 1998 Mar; 4(1-2):75-82. PubMed ID: 9740820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging psychoactive substance use among regular ecstasy users in Australia.
    Bruno R; Matthews AJ; Dunn M; Alati R; McIlwraith F; Hickey S; Burns L; Sindicich N
    Drug Alcohol Depend; 2012 Jul; 124(1-2):19-25. PubMed ID: 22209387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.
    Palamar JJ
    J Psychoactive Drugs; 2018; 50(1):88-93. PubMed ID: 28937933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
    Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
    Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine.
    Moore K; Dargan PI; Wood DM; Measham F
    Eur Addict Res; 2013; 19(5):276-82. PubMed ID: 23615495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel psychoactive substance and other drug use by young adults in Western australia.
    Goggin LS; Gately N; Bridle RI
    J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Topp L; Barker B; Degenhardt L
    Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for significant polydrug use among ecstasy-using college students.
    Wish ED; Fitzelle DB; O'Grady KE; Hsu MH; Arria AM
    J Am Coll Health; 2006; 55(2):99-104. PubMed ID: 17017306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE; Teesson M; Newton NC
    Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.